SS Innovations International Inc. (NASDAQ: SSII) is strengthening its position in the rapidly growing surgical robotics market by leveraging its proprietary SSi Mantra robotic surgery platform. The company's strategy focuses on reducing economic barriers to robotic surgery adoption, combining advanced technology with affordability, physician training, and international expansion. More than 200 SSi Mantra systems have been installed worldwide, supporting over 12,000 robotic procedures across more than 170 surgical indications.
The SSi Mantra platform includes telesurgery capabilities, allowing surgeons to perform procedures remotely. This feature is particularly valuable in regions with limited access to specialized surgical expertise. SS Innovations continues to pursue U.S. Food and Drug Administration clearance and European regulatory approvals while building its installed base in international markets.
Growing demand for minimally invasive surgery and broader access to robotic procedures are creating opportunities for emerging medical technology companies. Healthcare systems worldwide are seeking technologies that improve surgical precision while expanding patient access. SS Innovations has positioned itself to meet this demand by offering a system that the company says lowers acquisition and operating costs compared to competitors.
Unlike many developers focused primarily on premium hospital systems, SS Innovations has concentrated on making robotic surgery accessible to more hospitals, particularly in underserved regions. The company believes this approach can allow more facilities to introduce robotic-assisted procedures without sacrificing advanced capabilities.
For more information about SS Innovations International, visit the company's newsroom at https://ibn.fm/SSII.
